BioMarin Pharmaceuticals
BMRN
BMRN
459 hedge funds and large institutions have $17.6B invested in BioMarin Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 173 increasing their positions, 156 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
459
Holders Change
+12
Holders Change %
+2.68%
% of All Funds
10.51%
Holding in Top 10
9
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-25%
% of All Funds
0.21%
New
45
Increased
173
Reduced
156
Closed
28
Calls
$131M
Puts
$122M
Net Calls
+$9.91M
Net Calls Change
-$54.9M
Top Buyers
| 1 |
Capital International Investors
Los Angeles,
California
|
+$204M |
| 2 |
BlackRock
New York
|
+$97.2M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
+$84.3M |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$61M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$60.6M |
Top Sellers
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$198M |
| 2 |
Temasek Holdings
Singapore
|
-$107M |
| 3 |
SIG
Senator Investment Group
New York
|
-$94.2M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$78.5M |
| 5 |
Jennison Associates
New York
|
-$72.2M |
